JPWO2021092090A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021092090A5 JPWO2021092090A5 JP2022525169A JP2022525169A JPWO2021092090A5 JP WO2021092090 A5 JPWO2021092090 A5 JP WO2021092090A5 JP 2022525169 A JP2022525169 A JP 2022525169A JP 2022525169 A JP2022525169 A JP 2022525169A JP WO2021092090 A5 JPWO2021092090 A5 JP WO2021092090A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- palmar
- compound
- skin
- plantar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (1)
a.前記対象の前記手掌又は足底の皮膚に抗コリン性化合物を投与するステップ;及び
b.前記化合物が前記対象の前記手掌又は足底の皮膚に対する抗コリン性効果を有するのに十分な時間、前記対象の前記手掌又は足底の皮膚を遮蔽するステップ
を含む、前記方法。 A method for palmar or plantar administration of a compound to a subject in need thereof, the method comprising:
a. administering an anticholinergic compound to the skin of the palms or soles of the subject; and b. The method comprises masking the palmar or plantar skin of the subject for a sufficient period of time for the compound to have an anticholinergic effect on the palmar or plantar skin of the subject.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962931139P | 2019-11-05 | 2019-11-05 | |
US62/931,139 | 2019-11-05 | ||
PCT/US2020/058978 WO2021092090A1 (en) | 2019-11-05 | 2020-11-04 | Methods for palmar or plantar administration of pharmaceutical compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022554264A JP2022554264A (en) | 2022-12-28 |
JPWO2021092090A5 true JPWO2021092090A5 (en) | 2023-11-13 |
Family
ID=73599007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022525169A Pending JP2022554264A (en) | 2019-11-05 | 2020-11-04 | Methods for Palmar or Plantar Administration of Pharmaceutical Compositions |
Country Status (3)
Country | Link |
---|---|
US (1) | US20220401412A1 (en) |
JP (1) | JP2022554264A (en) |
WO (1) | WO2021092090A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2135444A1 (en) * | 1971-05-05 | 1972-12-22 | Amphoux Maurice | Antiperspiration under - glove - for use inside air-tight protective gloves |
CA2461696A1 (en) * | 2001-09-26 | 2003-04-03 | Alison B. Lukacsko | Compositions and methods for inhibiting eccrine perspiration in humans |
CN101340884A (en) * | 2005-10-19 | 2009-01-07 | 曼尼·马纳舍·辛格尔 | Methods for the treatment of hyperhidrosis |
US20100082088A1 (en) * | 2008-08-27 | 2010-04-01 | Ali Fassih | Treatment of sweating and hyperhydrosis |
US20150037269A1 (en) * | 2013-07-30 | 2015-02-05 | Glaxosmithkline Intellectual Property Development Limited | Topical compositions for treatment of excessive sweating and methods of use thereof |
GB2532811B (en) * | 2014-11-18 | 2017-07-26 | Atg Ceylon (Private) Ltd | Anti-Perspirant Glove |
-
2020
- 2020-11-04 WO PCT/US2020/058978 patent/WO2021092090A1/en active Application Filing
- 2020-11-04 JP JP2022525169A patent/JP2022554264A/en active Pending
- 2020-11-04 US US17/774,850 patent/US20220401412A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006501240A5 (en) | ||
RU2018110647A (en) | Aryl, heteroaryl and heterocyclic compounds for the treatment of diseases | |
EA201270221A1 (en) | TREATMENT OF CROWN DISEASE WITH LACQUINIMODE | |
CO2021008988A2 (en) | Combination of dextromethorphan and bupropion for the treatment of depression | |
JP2008505857A5 (en) | ||
RS52942B (en) | Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione | |
CO2018006358A2 (en) | Treatment of fabry disease in patients not treated and previously treated with ert | |
PE20142319A1 (en) | MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE | |
RU2008119454A (en) | MEDICINE FOR PROTECTION OF MOTOR NEURON IN PATIENTS WITH LATERAL AMYOTROPHIC SCLEROSIS | |
RU2018125622A (en) | METHOD OF APPLICATION OF CARRYMICIN AGAINST RESISTANCE OF INFECTION PROVIDED BY MYCOBACTERIA TUBERCULOSIS | |
PH12020551911A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
JP2020529995A5 (en) | ||
MX2020001342A (en) | Use of gaboxadol in the treatment of diabetes and related conditions. | |
WO2017182873A3 (en) | Peptide-oligourea foldamer compounds and methods of their use | |
EA200800075A1 (en) | DOSING CIRCUIT FOR WISE | |
JP2013536837A5 (en) | ||
DE602004024221D1 (en) | TREATMENT OF INFLAMMATORY ENDURANCE DISEASES WITH 2-METHYLENE-19-NOR-VITAMIN D COMPOUNDS | |
JP2005508963A5 (en) | ||
JPWO2021092090A5 (en) | ||
DK1732551T3 (en) | Perhexilin for the treatment of chronic heart failure | |
JP2004521140A5 (en) | ||
CR8584A (en) | PIPERAZINAS DERIVED FROM UREA FOR THE TREATMENT OF ENDOMETROSIS | |
Mehta et al. | Generalized lichen nitidus in childhood | |
ATE298240T1 (en) | SEPARATE DOSE THERAPIES WITH VASCULAR DAMAGED ACTIVITY | |
JP2003212765A (en) | Solution for stopping symptom of athlete's foot |